if (have_posts()) : while (have_posts()) : the_post(); ?>
Understanding the treatment affordability of high-cost SCD therapies in Egypt, India, Nigeria and Pakistan

Value & Access

Understanding the treatment affordability of high-cost SCD therapies in Egypt, India, Nigeria and Pakistan

Project Scope

To understand the treatment affordability and accessibility of high cost therapies for SCD in Egypt, India, Pakistan, and Nigeria

Egypt

Egypt

India

India

Pakistan

Pakistan

Nigeria

Nigeria

Challenge

The client aims to assess the perception of their new product among healthcare providers, patients, and key stakeholders. Additionally, they seek to understand the access pathways for high-cost treatments, potential pricing strategies, and to identify funding and accessibility challenges that could affect its adoption and utilization

Solution

In-depth primary research was conducted to gather understanding on:

  • Access process for high-cost treatments Barriers to accessing SCD treatments
  • Pricing strategies and financial assistance programs to improve affordability
  • Effective sponsored programs backed by manufacturers and NGOs to enhance access to new SCD treatments
  • Role of government and non-governmental organizations in facilitating treatment access

Results

  • Helped client gain clear insights into the accessibility, affordability challenges, and access proces and price potential for SCD therapies in target market
  • Helped the client to understand the feasibility and potential adoption of various manufacturer-sponsored programs designed to support access to SCD therapies by evaluating the effectiveness of assistance initiatives and other affordability strategies aimed at improving patient access to essential treatments

Note: NGOs: Non-governmental Organizations, SCD: Sickle Cell Disease